Automated blood collection market seen reaching $3.46 billion by 2030

The Business Research Company says the automated blood collection market is projected to grow from $1.52 billion in 2025 to $3.46 billion by 2030 as hospitals and labs invest in more precise, efficient sampling systems. North America led the market in 2025, while rising blood donations and automation in healthcare are expected to support demand.

Why it matters: - Automated blood collection is moving from a niche technology to a broader hospital and lab workflow tool. - The market’s projected growth points to stronger demand for systems that can improve accuracy, reduce manual labor and support safer blood draws. - Rising blood donation volumes add another use case that can expand adoption.

What happened: - The Business Research Company released a report on the automated blood collection market on July 27, 2026. - The report estimates the market will increase from $1.52 billion in 2025 to $1.8 billion in 2026. - The report projects the market will reach $3.46 billion by 2030. - North America held the largest regional share in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Automated blood collection uses technology and automated devices to collect blood samples more accurately and efficiently. - The systems reduce dependence on manual labor, improve accuracy, minimize errors and enhance patient comfort and safety during blood draws. - The market’s historical growth has been supported by continued use of manual blood collection techniques, dependence on traditional venipuncture, limited availability of automated systems, higher diagnostic and hospital procedure volumes, and demand for precise diagnostic results. - The forecast through 2030 is driven by robotic venipuncture advances, wider point-of-care testing, greater investment in hospital automation, expansion of diagnostic and pathology labs, and supportive regulations for automated sampling. - The report says a key driver is the rise in blood donations worldwide. - NHS Blood and Transplant in the UK reported 119,371 new blood donations in 2023-2024, up from 119,016 in the prior year. - The company’s 2026 reports also include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and key technology and future trend analysis. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The report signals that automation in blood collection is being pulled by both clinical demand and operational efficiency goals. - The emphasis on regional coverage and strategic intelligence suggests the company is positioning the report for buyers tracking expansion, competition and product planning. - The blood donation data suggests growth is not limited to hospital procurement and may also be tied to public health and collection-center operations.

What's next: - The market is expected to keep expanding as hospitals, labs and diagnostic networks adopt more automated sampling tools. - Regional competition will likely hinge on where automation, point-of-care testing and lab infrastructure expand fastest. - The report points to continued interest in robotic venipuncture and hospital automation through 2030.

The bottom line: - Automated blood collection is projected to nearly double by 2030, with automation, diagnostics growth and blood donation demand driving the market forward.